Investigates resistance development in Candida auris, suggesting persistence in clinical settings.
can acquire echinocandin resistance without compromising pathogenicity, supporting its persistence and spread in clinical settings.
No takes yet. Share an insight, caveat, or question.
Bohner et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: